According to recent reports, an ongoing Accutane lawsuit that began in 2007 is nearing resolution. The lawsuit was filed by a man who claimed the acne medication caused him to develop an inflammatory bowel disease (IBD).
Accutane Lawsuit Update 7/2/12: Last month, pharmaceutical giant Roche Holding AG was ordered to pay a total of $18 million to settle a pair of lawsuits claiming that Accutane caused the plaintiffs’ inflammatory bowel disease (IBD). The company has now lost nine of 13 lawsuits brought by former Accutane users that have gone to trial since April 2007. Click here to learn more.
What’s the problem?
July 8, 2010 – The lawsuit, filed by Jason Peipert of Grainte City, Illinois, alleges that Accutane (isotretinoin) caused him to develop the severe gastrointestinal disorder known as inflammatory bowel disease. Peipert filed the lawsuit against Accutane manufacturer Hoffman-LaRoche, Inc., Roche Laboratories, and Dr. Daniel Goran, the doctor who prescribed him the medication.
After being delayed on multiple occasions, the defendants settled with Peipert in March 2010, following mediation, but Peipert’s case against Dr. Goran remained open and was set to go to trial April 19, 2010. According to reports, Dr. Goran settled with Peipert just before the April 19 trial date.
Earlier this year, a jury awarded $25.16 million to the plaintiff in a different Accutane lawsuit, Andy McCarrell, who alleged that he developed chronic ulcerative colitis a year after finishing his Accutane treatment. McCarrell said he suffered from severe complications of inflammatory bowel disease, which ultimately resulted in the removal of his colon.
IBD is a group of inflammatory conditions of the intestines. The main forms of the condition are Crohn’s disease and ulcerative colitis. Although rarely fatal on its own, people who develop IBD usually suffer a limited quality of life due to the pain, liver problems, arthritis, vomiting, weight loss, and other troubling symptoms of the disease. Those with IBD also have an increased risk of colorectal cancer.